Skip to main content

Table 2 The characteristics of included studies (Case-Control and Cross- Sectional Studies)

From: The association between periodontal diseases and helicobacter pylori: an updated meta-analysis of observational studies

Authors

Years

Design

Study

Sample Size

Population

Age

Country

A

B

C

D

Methods

Sample

NOS

Nisha KJ, et al. [26]

2016

Cross Sectional

Community

499

General Population

43.67

India

180

113

90

117

Rapid Urease Test

Oral Sample

7

Nisha KJ, et al. [26]

2016

Cross Sectional

Community

500

General Population

43.67

India

209

84

136

71

Serology

Oral Sample

6

Dye BA, et al.  [19]

2002

Cross Sectional

Community

4504

General Population

 

USA

202

951

291

3030

ELISA

Oral Sample

8

LX Gong, et al. [3]

2011

Case Control

Community

562

Chronic Periodontal

 

China

438

58

41

25

Rapid Urease Test

Oral Sample

8

Zheng P, et al. [28]

2015

Case Control

Community

140

Elderly Population

63.8

China

40

30

24

46

Polymerase Chain Reaction (PCR)

Oral Sample

7

MY Wang, et al. [5]

2015

Case Control

Community

200

Chronic Periodontal

 

China

103

17

59

21

Rapid Urease Test

Oral Sample

7

Jing Li, et al. [30]

2015

Case Control

Community

176

Chronic Periodontal

 

China

69

16

52

37

Rapid Urease Test

Oral Sample

8

Umeda M, et al. [31]

2003

Cross Sectional

Hospital

36

Chronic Periodontal

54.5

Japan

7

1

10

10

Polymerase Chain Reaction (PCR)

Oral Sample

7

Anand PS, et al. [1]

2006

Case Control

Hospital

134

Gastric Patients

40

India

30

20

35

49

Rapid Urease Test

Oral Sample

7

Souto R, et al. [32]

2008

Cross Sectional

Hospital

225

Chronic Periodontal

39.3

Brazil

40

4

129

52

Polymerase Chain Reaction (PCR)

Oral Sample

8

Al Asqah M, et al. [33]

2009

Case Control

Hospital

101

Gastric Patients

40.77

Saudi Arabia

49

17

13

22

Rapid Urease Test

Oral Sample

8

Al Asqah M, et al. [33]

2009

Case Control

Hospital

101

Gastric Patients

40.77

Saudi Arabia

37

17

13

22

Rapid Urease Test

Stomach

8

Medina ML, et al. [34]

2010

Case Control

Hospital

98

Gastric Patients

44

Argentina

15

3

28

52

Polymerase Chain Reaction (PCR)

Oral Sample

8

Silva DG, et al. [18]

2010

Cross Sectional

Hospital

115

Gastric Patients

50

Brazil

36

22

31

26

Polymerase Chain Reaction (PCR)

Oral Sample

6

Salehi MR, et al. [16]

2013

Case Control

Hospital

100

Chronic Periodontal

35.53

Iran

9

12

41

38

Polymerase Chain Reaction (PCR)

Oral Sample

6

Sujatha S, et al. [35]

2015

Cross Sectional

Hospital

40

Gastric Patients

45.15

India

26

2

6

6

Rapid Urease Test

Oral Sample

7

Yang J, et al. [36]

2016

Case Control

Hospital

212

Chronic Periodontal

56.5

China

78

58

25

51

Polymerase Chain Reaction (PCR)

Oral Sample

7

Tahbaz SV, et al. [37]

2017

Case Control

Hospital

100

Chronic Periodontal

54.5

Iran

4

1

46

49

Polymerase Chain Reaction (PCR)

Oral Sample

7

Riggio MP, et al. [38]

1999

Cross Sectional

Hospital

73

Chronic Periodontal

45.1

UK

11

18

13

31

Polymerase Chain Reaction (PCR)

Oral Sample

7

Li Wang, et al. [18]

2001

Case Control

Hospital

106

Chronic Periodontal

 

China

21

41

4

40

Polymerase Chain Reaction (PCR)

Oral Sample

7

Al-Refai AN, et al. [40]

2002

Case Control

Hospital

135

Chronic Periodontal

37.2

Saudi Arabia

67

8

52

8

Rapid Urease Test

Oral Sample

8

YH Jiang, et al. [20]

2002

Case Control

Hospital

60

Chronic Periodontal

 

China

29

11

7

13

Polymerase Chain Reaction (PCR)

Oral Sample

6

Jing Gao, et al. [42]

2011

Case Control

Hospital

76

Chronic Periodontal

 

China

24

13

15

24

Polymerase Chain Reaction (PCR)

Oral Sample

7

A Tsimpiris, et al. [43]

2021

Case Control

Hospital

65

Chronic Periodontal

55.5

Greece

6

27

7

25

Polymerase Chain Reaction (PCR)

Oral Sample

7

Almashhadany DA, et al. [44]

2022

Cross Sectional

Hospital

280

Chronic Periodontal

51.7

Iraq

64

49

53

114

Rapid Urease Test

Oral Sample

7

  1. A: Exposed cases (the number of patients with H. Pylori in all the PDs patients), B: Exposed non-cases (the number of patients with H. Pylori in the people without PDs), C: Unexposed cases (the number of people without H. Pylori in all the PDs patients), D: Unexposed non-cases (the number of the people without H. Pylori in the people without PDs), NOS: the Newcastle - Ottawa Quality Assessment Scale,